
Aptorum Group Limited APM
$ 0.79
-1.15%
Annual report 2024
added 03-07-2026
Aptorum Group Limited Operating Cycle 2011-2026 | APM
Annual Operating Cycle Aptorum Group Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 4.89 | 20.6 | 14.8 | 1.35 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.6 | 1.35 | 10.4 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
AbCellera Biologics
ABCL
|
173 | $ 3.49 | 0.58 % | $ 1.04 B | ||
|
Frequency Therapeutics
FREQ
|
76.1 | - | - | $ 528 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Grifols, S.A.
GRFS
|
0.000171 | $ 7.81 | -2.01 % | $ 6.83 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
BioCardia
BCDA
|
101 | $ 1.26 | -0.79 % | $ 26.7 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Anika Therapeutics
ANIK
|
325 | $ 14.2 | -0.7 % | $ 208 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 6.68 | -4.57 % | $ 183 M | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
AVEO Pharmaceuticals
AVEO
|
111 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
360 | $ 2.54 | -5.22 % | $ 16 M | ||
|
Certara
CERT
|
89.6 | $ 6.67 | 1.6 % | $ 1.07 B |